GSK Investigational Site [clinicaltrials_resource:dc5881f0c915a78ee3b5ea289a61b534]
Study To Evaluate The Effects Of GW856553 On Endothelial Function/Vascular Compliance In Subjects With Dyslipidaemia. [clinicaltrials:NCT00474864]First Time in Human Study of Intravenous Interleukin-18 Antibody [clinicaltrials:NCT01035645]PK Study of IV Formulation of GW856553 [clinicaltrials:NCT01039961]SAP Depleter Dose Escalation Study in Healthy Volunteers [clinicaltrials:NCT01323985]A Study to Characterize Event Related Potential Markers of Attentional Bias Towards Words and Images of Food [clinicaltrials:NCT01366508]Effect of GSK962040 on Oesophageal Function [clinicaltrials:NCT01366560]A Study to Examine the Pharmacodynamic Effects of GSK1034702 on Neurophysiological Biomarkers of Cognition in Nicotine Abstained Otherwise Healthy Smokers [clinicaltrials:NCT01371799]SAP Depleter Dose Assessment Study in Patients [clinicaltrials:NCT01406314]LRRK2 Mutation and Parkinson's Disease [clinicaltrials:NCT01424475]Gabapentin and Donepezil Combination on Experimental Human Pain Models [clinicaltrials:NCT01485185]A Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of an Intravenous Infusion of GW328267X in Healthy Volunteers [clinicaltrials:NCT01640990]Investigation of Topical SB705498 on Healthy Volunteers [clinicaltrials:NCT01673529]To Evaluate the Influence of the A118G Polymorphism in the mu Opioid Receptor Gene (OPRM1) on Effects of GSK1521498 and Naltrexone on Physiological and Behavioural Markers of Brain Function in Healthy Social Drinkers [clinicaltrials:NCT01738867]A Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Doses of GSK2256294 in Healthy Volunteers, and Single and Repeat Doses of GSK2256294 in Adult Male Moderately Obese Smokers [clinicaltrials:NCT01762774]Phase I Methodology Study to Validate the Cantharidin Blister Model in Healthy Volunteers [clinicaltrials:NCT01762787]A First Time in Human Study Exploring Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) of GSK2618960 in Healthy Volunteers and Patients With Relapsing Remitting Multiple Sclerosis (RRMS) [clinicaltrials:NCT01808482]Characterisation of T-cell Response to Keyhole Limpet Hemocyanin (KLH) and Tuberculin Purified Protein Derivative (PPD) [clinicaltrials:NCT01910662]Single Dose Escalation Trial to Evaluate the Safety, Tolerability Pharmacokinetics and Pharmacodynamics of GSK3050002 [clinicaltrials:NCT01984047]Single Ascending Doses Study of Anti- Interleukin-7 Receptor α Monoclonal Antibody (GSK2618960) in Healthy Volunteers [clinicaltrials:NCT02293161]
location [clinicaltrials_vocabulary:location]
GSK Investigational Site [clinicaltrials_resource:dc5881f0c915a78ee3b5ea289a61b534]
Bio2RDF identifier
dc5881f0c915a78ee3b5ea289a61b534
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:dc5881f0c915a78ee3b5ea289a61b534
address [clinicaltrials_vocabulary:address]
identifier
clinicaltrials_resource:dc5881f0c915a78ee3b5ea289a61b534
title
GSK Investigational Site
@en
type
label
GSK Investigational Site [clinicaltrials_resource:dc5881f0c915a78ee3b5ea289a61b534]
@en